title: After ENHANCE: is more LDL cholesterol lowering even better?
authors.affiliation: Medpace Reference Labs, Cincinnati, OH 45212, USA. esteinmrl@aol.com
authors.forename: Evan A
authors.initials: EA
authors.lastname: Stein
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000517:prevention & control*; D001384:Azetidines / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002340:Carotid Artery Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood*; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control; D050356:Lipid Metabolism; D019821:Simvastatin / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D015415:Biomarkers; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin; D000069438:Ezetimibe